Stay updated on Pembrolizumab & Epacadostat in Thymic Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Epacadostat in Thymic Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Epacadostat in Thymic Carcinoma Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, and the detailed study content is no longer visible. The standard site header/footer remains, but access to the trial record is blocked.
    Difference
    18%
    Check dated 2026-09-19T19:13:39.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    No Change Detected
  4. Check
    21 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.5 to v3.6.6. This reflects a minor update to the page's metadata rather than changes to the visible content.
    Difference
    0.1%
    Check dated 2026-08-29T19:35:20.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page's revision was updated from v3.6.4 to v3.6.5, indicating a minor platform update. There is no indication that study content, eligibility criteria, or results text has changed.
    Difference
    0.1%
    Check dated 2026-08-08T19:02:34.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.3 to v3.6.4, representing a minor update to the page metadata. This change does not affect the study details, endpoints, or eligibility criteria.
    Difference
    0.1%
    Check dated 2026-07-25T10:51:28.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    The page now shows a newer revision line (v3.6.3) for the study documents, replacing the previous v3.6.2. This reflects an updated protocol/SAP version in the documents section.
    Difference
    0.1%
    Check dated 2026-07-03T23:53:48.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    The page shows an updated revision tag, replacing v3.6.0 with v3.6.2, reflecting a newer deployment of the page system. This change does not modify study content or related data.
    Difference
    0.1%
    Check dated 2026-06-27T00:12:26.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Epacadostat in Thymic Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Epacadostat in Thymic Carcinoma Clinical Trial page.